Balance Sheet CME Group Inc.

Equities

CME

US12572Q1058

Financial & Commodity Market Operators

Market Closed - Nasdaq Other stock markets 21:00:00 18/07/2025 BST			5-day change	1st Jan Change
274.70 ^USD	-1.12%		-0.14%	+18.29%

07-18	LIVESTOCK-CME live cattle reach new high before pulling back	RE
07-17	CME Group, Nymex win dismissal of lawsuit related to carbon offsets	RE

c57dccf700.KZ9UwlrLhnuiDthhC6PBbZ-PYlOLeBKTpOgqlEpCXDA.bPcNhTS93CLwYYsrU8m0W8e4CwvZTGbckdFtxiQIBQRc-CaBELjhNI9c6A

Published financial data: CME GROUP INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	4.44B	4.34B	4.75B	5.25B	5.7B
Other Revenues, Total	428M	337M	255M	317M	422M
Total Revenues	4.87B	4.68B	5.01B	5.57B	6.12B
Gross Profit	4.87B	4.68B	5.01B	5.57B	6.12B
Selling General & Admin Expenses, Total	1.56B	1.48B	1.46B	1.57B	1.65B
Depreciation & Amortization - (IS)	153M	148M	135M	126M	115M
Amortization of Goodwill and Intangible Assets - (IS)	311M	238M	228M	227M	222M
Other Operating Expenses	174M	207M	187M	188M	201M
Other Operating Expenses, Total	2.2B	2.07B	2.01B	2.11B	2.18B
Operating Income	2.67B	2.6B	3B	3.46B	3.94B
Interest Expense, Total	-166M	-167M	-163M	-159M	-161M
Interest And Investment Income	183M	307M	2.2B	5.28B	4.08B
Net Interest Expenses	16.5M	140M	2.04B	5.12B	3.92B
Income (Loss) On Equity Invest.	191M	246M	301M	297M	351M
Currency Exchange Gains (Loss)	-9.7M	40.7M	13.2M	-22.6M	-5.2M
Other Non Operating Income (Expenses)	-122M	-88.5M	-1.86B	-4.69B	-3.67B
EBT, Excl. Unusual Items	2.75B	2.94B	3.49B	4.15B	4.53B
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	9.2M
Gain (Loss) On Sale Of Assets	-26.3M	431M	-	-	-
Asset Writedown	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	2.72B	3.37B	3.49B	4.15B	4.54B
Income Tax Expense	616M	737M	799M	927M	1.02B
Earnings From Continuing Operations	2.11B	2.64B	2.69B	3.23B	3.53B
Net Income to Company	2.11B	2.64B	2.69B	3.23B	3.53B
Minority Interest	-1.2M	-500K	-	-	-
Net Income - (IS)	2.11B	2.64B	2.69B	3.23B	3.53B
Preferred Dividend and Other Adjustments	-	19.3M	33.8M	40.6M	44.3M
Net Income to Common Incl Extra Items	2.11B	2.62B	2.66B	3.19B	3.48B
Net Income to Common Excl. Extra Items	2.11B	2.62B	2.66B	3.19B	3.48B
Per Share Items
Net EPS - Basic	5.88	7.3	7.41	8.87	9.69
Basic EPS - Continuing Operations	5.88	7.3	7.41	8.87	9.69
Basic Weighted Average Shares Outstanding	358M	358M	359M	359M	359M
Net EPS - Diluted	5.87	7.29	7.4	8.86	9.67
Diluted EPS - Continuing Operations	5.87	7.29	7.4	8.86	9.67
Diluted Weighted Average Shares Outstanding	359M	359M	359M	360M	360M
Normalized Basic EPS	4.8	5.13	6.08	7.23	7.88
Normalized Diluted EPS	4.79	5.12	6.07	7.22	7.87
Dividend Per Share	3.4	3.6	4	4.4	4.6
Payout Ratio	100.23	83.04	97.86	100.29	101.66
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	3.14B	2.99B	3.37B	3.81B	4.27B
EBITA	2.98B	2.84B	3.23B	3.68B	4.16B
EBIT	2.67B	2.6B	3B	3.46B	3.94B
EBITDAR	3.19B	3.04B	3.41B	3.86B	4.32B
Total Revenues (As Reported)	4.88B	4.69B	5.02B	5.58B	6.13B
Effective Tax Rate - (Ratio)	22.62	21.84	22.9	22.33	22.36
Current Domestic Taxes	628M	683M	798M	958M	1.03B
Current Foreign Taxes	28.8M	19M	24.9M	44.9M	52.3M
Total Current Taxes	657M	702M	822M	1B	1.08B
Deferred Domestic Taxes	-34.5M	6M	-23.6M	-11.9M	-66.6M
Deferred Foreign Taxes	-7.1M	28.8M	400K	-63.1M	200K
Total Deferred Taxes	-41.6M	34.8M	-23.2M	-75M	-66.4M
Normalized Net Income	1.72B	1.84B	2.18B	2.6B	2.83B
Interest on Long-Term Debt	3.3M	3.1M	2.8M	2.5M	2.2M
Non-Cash Pension Expense	-4.5M	-6.5M	-8.9M	-2.8M	-4.9M
Supplemental Operating Expense Items
General and Administrative Expenses	635M	581M	646M	686M	744M
Research And Development Expense From Footnotes	198M	193M	189M	219M	256M
Net Rental Expense, Total	53.5M	53.5M	46.7M	45.7M	42M
Imputed Operating Lease Interest Expense	16.79M	17.64M	15.25M	14.88M	14.03M
Imputed Operating Lease Depreciation	36.71M	35.86M	31.45M	30.82M	27.97M
Stock-Based Comp., SG&A Exp. (Total)	96.9M	76.4M	84.8M	83.7M	90.4M
Total Stock-Based Compensation	96.9M	76.4M	84.8M	83.7M	90.4M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.63B	2.83B	2.72B	2.91B	2.89B
Short Term Investments	101M	115M	96M	112M	113M
Total Cash And Short Term Investments	1.73B	2.95B	2.82B	3.02B	3.01B
Accounts Receivable, Total	461M	434M	483M	536M	573M
Total Receivables	461M	434M	483M	536M	573M
Restricted Cash	4.7M	4.8M	4.9M	5.2M	6.3M
Other Current Assets, Total	87.08B	158B	136B	91.33B	99.45B
Total Current Assets	89.28B	162B	139B	94.89B	103B
Gross Property Plant And Equipment	2.02B	1.97B	1.98B	1.68B	1.7B
Accumulated Depreciation	-961M	-1.04B	-1.15B	-933M	-1.02B
Net Property Plant And Equipment	1.06B	931M	838M	744M	672M
Long-term Investments	1.02B	2.44B	2.76B	67.8M	2.58B
Goodwill	10.8B	10.53B	10.48B	10.5B	10.49B
Other Intangibles, Total	22.04B	20.71B	20.44B	20.23B	20B
Other Long-Term Assets, Total	456M	413M	574M	3.28B	677M
Total Assets	125B	197B	174B	130B	137B
Liabilities
Accounts Payable, Total	69.3M	48.8M	121M	90.6M	79.9M
Short-term Borrowings	-	749M	16M	-	-
Current Portion of Long-Term Debt	-	-	-	-	750M
Current Portion of Leases	52.2M	55.2M	58.1M	55.1M	53.4M
Unearned Revenue Current, Total	37.3M	15.2M	12.7M	13.2M	-
Other Current Liabilities	88.04B	160B	137B	93.26B	101B
Total Current Liabilities	88.2B	160B	138B	93.42B	102B
Long-Term Debt	3.44B	2.7B	3.42B	3.43B	2.68B
Long-Term Leases	576M	525M	451M	403M	340M
Deferred Tax Liability Non Current	5.61B	5.39B	5.36B	5.33B	5.25B
Other Non Current Liabilities	483M	371M	375M	395M	381M
Total Liabilities	98.31B	169B	147B	103B	111B
Common Stock, Total	3.6M	3.6M	3.6M	3.6M	3.6M
Additional Paid In Capital	21.19B	22.19B	22.26B	22.33B	22.4B
Retained Earnings	5B	5.15B	4.75B	4.46B	4.19B
Comprehensive Income and Other	135M	53.5M	-133M	-55.6M	-106M
Total Common Equity	26.32B	27.4B	26.88B	26.74B	26.49B
Minority Interest	31.6M	-	-	-	-
Total Equity	26.35B	27.4B	26.88B	26.74B	26.49B
Total Liabilities And Equity	125B	197B	174B	130B	137B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	359M	359M	360M	360M	360M
ECS Total Common Shares Outstanding	358M	359M	359M	359M	360M
Book Value / Share	73.5	76.41	74.89	74.43	73.66
Tangible Book Value	-6.52B	-3.84B	-4.05B	-3.98B	-4B
Tangible Book Value Per Share	-18.21	-10.7	-11.28	-11.09	-11.11
Total Debt	4.07B	4.03B	3.95B	3.88B	3.82B
Net Debt	2.34B	1.08B	1.13B	860M	816M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-7.9M	-16.3M	-15.3M	700K	-3.5M
Debt Equivalent Oper. Leases	428M	428M	374M	366M	336M
Minority Interest, Total (Incl. Fin. Div)	31.6M	-	-	-	-
Equity Method Investments, Total	1.02B	2.44B	2.76B	67.8M	2.57B
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	7.7M	-	-	-	-
Buildings, Total	167M	132M	132M	131M	131M
Machinery, Total	493M	519M	551M	413M	433M
Full Time Employees	4.37K	3.48K	3.46K	3.56K	3.76K
Accumulated Allowance for Doubtful Accounts (Supple)	5.4M	5.6M	8.1M	7.1M	9M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	2.11B	2.64B	2.69B	3.23B	3.53B
Depreciation & Amortization - CF	153M	148M	135M	126M	115M
Amortization of Goodwill and Intangible Assets - (CF)	311M	238M	228M	227M	222M
Depreciation & Amortization, Total	464M	385M	363M	353M	337M
(Gain) Loss From Sale Of Asset	26.3M	-30.4M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	5.5M	-117M	-4.8M	-72.1M	-3.6M
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-7.7M	-425M	-	-	-
Stock-Based Compensation (CF)	96M	75.2M	84.3M	82.9M	89.5M
Other Operating Activities, Total	-33.3M	39.7M	18.1M	-40.6M	-69.4M
Change In Accounts Receivable	28.2M	-45.7M	-51.1M	-51.5M	-39.4M
Change In Accounts Payable	7.4M	-18.6M	72.5M	-30.8M	-10.7M
Change In Income Taxes	4.7M	-120M	-148M	-77.1M	-117M
Change in Other Net Operating Assets	18.9M	23M	31.2M	64.2M	-21.1M
Cash from Operations	2.72B	2.4B	3.06B	3.45B	3.69B
Capital Expenditure	-198M	-127M	-89.7M	-76.4M	-94M
Cash Acquisitions	-	-52.9M	-	-	-
Sale (Purchase) of Real Estate properties	-	39.3M	-	-	-
Investment in Marketable and Equity Securities, Total	22M	199M	-400M	97.3M	11.4M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-176M	58.4M	-490M	20.9M	-82.6M
Short Term Debt Issued, Total	-	71.17B	-	-	-
Long-Term Debt Issued, Total	-	-	741M	-	-
Total Debt Issued	-	71.17B	741M	-	-
Short Term Debt Repaid, Total	-305M	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-756M	-16.4M	-
Total Debt Repaid	-305M	-	-756M	-16.4M	-
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-41.4M	-31.7M	-24.8M	-21.4M	-33M
Issuance of Preferred Stock	-	965M	-	-	-
Common Dividends Paid	-2.11B	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-2.19B	-2.63B	-3.24B	-3.58B
Common & Preferred Stock Dividends Paid	-2.11B	-2.19B	-2.63B	-3.24B	-3.58B
Other Financing Activities, Total	-2.2M	-3.1M	-22.71B	-45.07B	8.69B
Cash from Financing	-2.46B	69.91B	-25.38B	-48.34B	5.08B
Net Change in Cash	81.9M	72.37B	-22.82B	-44.86B	8.68B
Supplemental Items
Cash Interest Paid	133M	133M	133M	130M	130M
Cash Income Tax Paid (Refund)	653M	755M	973M	1.11B	1.2B
Levered Free Cash Flow	1.99B	2.04B	2.7B	2.57B	2.68B
Unlevered Free Cash Flow	2.09B	2.15B	2.8B	2.67B	2.78B
Change In Net Working Capital	-56.3M	-186M	-569M	-144M	12.5M
Net Debt Issued / Repaid	-305M	71.17B	-15.2M	-16.4M	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	1.67	1.01	1.01	1.42	1.84
Return on Total Capital	5.48	5.26	6.03	7.03	8.08
Return On Equity %	8.02	9.81	9.92	12.03	13.25
Return on Common Equity	8.03	9.74	9.79	11.88	13.08
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	31.99	31.67	29.08	28.19	26.89
EBITDA Margin %	64.43	63.9	67.19	68.43	69.82
EBITA Margin %	61.28	60.74	64.49	66.17	67.94
EBIT Margin %	54.89	55.66	59.95	62.1	64.32
Income From Continuing Operations Margin %	43.25	56.35	53.73	57.93	57.61
Net Income Margin %	43.23	56.34	53.73	57.93	57.61
Net Avail. For Common Margin %	43.23	55.93	53.05	57.2	56.88
Normalized Net Income Margin	35.25	39.29	43.55	46.61	46.28
Levered Free Cash Flow Margin	40.8	43.68	53.94	46.07	43.8
Unlevered Free Cash Flow Margin	42.93	45.91	55.98	47.86	45.44
Asset Turnover
Asset Turnover	0.05	0.03	0.03	0.04	0.05
Fixed Assets Turnover	4.6	4.7	5.66	7.04	8.65
Receivables Turnover (Average Receivables)	9.32	9.69	10.36	10.31	10.28
Short Term Liquidity
Current Ratio	1.01	1.01	1.01	1.02	1.01
Quick Ratio	0.02	0.02	0.02	0.04	0.03
Operating Cash Flow to Current Liabilities	0.03	0.01	0.02	0.04	0.04
Days Sales Outstanding (Average Receivables)	39.26	37.65	35.23	35.4	35.6
Long Term Solvency
Total Debt/Equity	15.45	14.69	14.69	14.53	14.43
Total Debt / Total Capital	13.38	12.81	12.81	12.68	12.61
LT Debt/Equity	15.25	11.76	14.41	14.32	11.4
Long-Term Debt / Total Capital	13.21	10.25	12.57	12.5	9.96
Total Liabilities / Total Assets	78.86	86.08	84.57	79.39	80.73
EBIT / Interest Expense	16.09	15.61	18.46	21.7	24.47
EBITDA / Interest Expense	19.2	18.23	20.97	24.19	26.82
(EBITDA - Capex) / Interest Expense	18.01	17.47	20.42	23.72	26.24
Total Debt / EBITDA	1.28	1.32	1.16	1.01	0.89
Net Debt / EBITDA	0.73	0.35	0.33	0.22	0.19
Total Debt / (EBITDA - Capex)	1.36	1.38	1.19	1.03	0.91
Net Debt / (EBITDA - Capex)	0.78	0.37	0.34	0.23	0.19
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	0.26	-3.92	9.74	11.19	9.9
Gross Profit, 1 Yr. Growth %	0.26	-3.92	9.74	11.19	9.9
EBITDA, 1 Yr. Growth %	0.27	-4.71	17.06	13.24	12.14
EBITA, 1 Yr. Growth %	0.46	-4.77	18.46	14.07	12.85
EBIT, 1 Yr. Growth %	0.65	-2.58	20.62	15.17	13.83
Earnings From Cont. Operations, 1 Yr. Growth %	-0.44	25.19	2.05	19.89	9.29
Net Income, 1 Yr. Growth %	-0.53	25.23	2.07	19.89	9.29
Normalized Net Income, 1 Yr. Growth %	-0.19	7.11	23.48	19	9.11
Diluted EPS Before Extra, 1 Yr. Growth %	-0.68	24.19	1.51	19.73	9.14
Accounts Receivable, 1 Yr. Growth %	-6.2	-5.81	11.21	10.84	7
Net Property, Plant and Equip., 1 Yr. Growth %	-0.03	-12.05	-10.01	-11.14	-9.78
Total Assets, 1 Yr. Growth %	65.74	57.85	-11.49	-25.53	5.97
Tangible Book Value, 1 Yr. Growth %	-5.6	-41.16	5.55	-1.63	0.35
Common Equity, 1 Yr. Growth %	0.73	4.1	-1.9	-0.52	-0.94
Cash From Operations, 1 Yr. Growth %	1.6	-11.53	27.21	13.02	6.85
Capital Expenditures, 1 Yr. Growth %	-19.58	-35.6	-29.48	-14.83	23.04
Levered Free Cash Flow, 1 Yr. Growth %	-7.27	2.87	37.01	-5.04	4.47
Unlevered Free Cash Flow, 1 Yr. Growth %	-7.24	2.75	35.02	-4.93	4.34
Dividend Per Share, 1 Yr. Growth %	13.33	5.88	11.11	10	4.55
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.31	-1.96	1.27	8.97	10.42
Gross Profit, 2 Yr. CAGR %	6.31	-1.96	1.27	8.97	10.42
EBITDA, 2 Yr. CAGR %	3.49	-2.25	3.56	12.9	12.69
EBITA, 2 Yr. CAGR %	3.04	-2.19	4.04	13.87	13.46
EBIT, 2 Yr. CAGR %	-0.15	-0.98	5.98	15.23	14.5
Earnings From Cont. Operations, 2 Yr. CAGR %	3.57	11.64	13.03	10.61	14.46
Net Income, 2 Yr. CAGR %	3.58	11.61	13.06	10.62	14.46
Normalized Net Income, 2 Yr. CAGR %	-0.52	3.39	12.73	18.22	13.95
Diluted EPS Before Extra, 2 Yr. CAGR %	1.39	11.06	12.28	10.24	14.31
Accounts Receivable, 2 Yr. CAGR %	-8.69	-6.01	2.35	11.03	8.91
Net Property, Plant and Equip., 2 Yr. CAGR %	53.58	-6.23	-11.04	-10.58	-10.46
Total Assets, 2 Yr. CAGR %	26.85	61.75	18.2	-18.81	-11.17
Tangible Book Value, 2 Yr. CAGR %	-7.15	-25.47	-21.19	1.9	-0.64
Common Equity, 2 Yr. CAGR %	0.77	2.4	1.06	-1.21	-0.73
Cash From Operations, 2 Yr. CAGR %	5.48	-5.19	6.08	19.9	9.89
Capital Expenditures, 2 Yr. CAGR %	30.09	-28.03	-32.61	-22.5	2.37
Levered Free Cash Flow, 2 Yr. CAGR %	23.4	-2.33	16.61	12.04	-0.4
Unlevered Free Cash Flow, 2 Yr. CAGR %	22.06	-2.37	15.8	11.38	-0.4
Dividend Per Share, 2 Yr. CAGR %	10.19	9.54	8.47	10.55	7.24
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.14	2.78	0.96	4.48	9.28
Gross Profit, 3 Yr. CAGR %	10.14	2.78	0.96	4.48	9.28
EBITDA, 3 Yr. CAGR %	7.73	0.68	2.45	6.69	12.64
EBITA, 3 Yr. CAGR %	7.59	0.36	2.83	7.28	13.53
EBIT, 3 Yr. CAGR %	5.12	-0.96	4.17	8.96	14.76
Earnings From Cont. Operations, 3 Yr. CAGR %	-19.67	10.32	8.35	15.27	10.17
Net Income, 3 Yr. CAGR %	-19.68	10.35	8.33	15.29	10.17
Normalized Net Income, 3 Yr. CAGR %	2.82	1.96	8.25	14.78	15.1
Diluted EPS Before Extra, 3 Yr. CAGR %	-21.08	8.48	7.78	14.71	9.88
Accounts Receivable, 3 Yr. CAGR %	8.65	-7.74	-0.59	5.1	9.67
Net Property, Plant and Equip., 3 Yr. CAGR %	38.34	27.54	-7.51	-11.07	-10.31
Total Assets, 3 Yr. CAGR %	18.04	36.44	32.3	1.33	-11.27
Tangible Book Value, 3 Yr. CAGR %	11.69	-20.25	-16.31	-15.15	1.38
Common Equity, 3 Yr. CAGR %	5.5	1.87	0.95	0.53	-1.12
Cash From Operations, 3 Yr. CAGR %	15.75	-0.53	4.57	8.35	15.38
Capital Expenditures, 3 Yr. CAGR %	34.1	2.91	-28.52	-27.14	-9.59
Levered Free Cash Flow, 3 Yr. CAGR %	11.23	16.14	8.04	8.89	9.46
Unlevered Free Cash Flow, 3 Yr. CAGR %	11.28	15.25	7.54	8.43	8.99
Dividend Per Share, 3 Yr. CAGR %	8.8	8.74	10.06	8.97	8.51
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.92	5.41	6.56	5.26	4.68
Gross Profit, 5 Yr. CAGR %	7.92	5.41	6.56	5.26	4.68
EBITDA, 5 Yr. CAGR %	7.08	4.08	6.04	5.4	6.43
EBITA, 5 Yr. CAGR %	7.29	4.15	6.15	5.56	6.96
EBIT, 5 Yr. CAGR %	5.98	3.22	5.47	5.22	8.19
Earnings From Cont. Operations, 5 Yr. CAGR %	11.05	11.44	-7.91	10.44	10.75
Net Income, 5 Yr. CAGR %	11.04	11.44	-7.91	10.46	10.75
Normalized Net Income, 5 Yr. CAGR %	6.59	5.16	6.68	8.4	10.49
Diluted EPS Before Extra, 5 Yr. CAGR %	9.73	9.98	-9.12	9.18	10.35
Accounts Receivable, 5 Yr. CAGR %	5.21	3.58	6.08	-0.65	3.11
Net Property, Plant and Equip., 5 Yr. CAGR %	16.57	16.96	15.95	10.65	-8.7
Total Assets, 5 Yr. CAGR %	13.1	23.19	18.11	10.86	12.81
Tangible Book Value, 5 Yr. CAGR %	-0.63	-10.94	-2.85	-12.03	-10.36
Common Equity, 5 Yr. CAGR %	5.07	6.14	3.7	0.62	0.27
Cash From Operations, 5 Yr. CAGR %	12.12	6.76	11.78	7.19	6.67
Capital Expenditures, 5 Yr. CAGR %	11.58	6.74	1.84	-8.12	-17.48
Levered Free Cash Flow, 5 Yr. CAGR %	4.28	3.84	13.35	14.48	4.58
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.4	3.95	13.07	13.69	4.29
Dividend Per Share, 5 Yr. CAGR %	11.2	8.45	8.67	9.46	8.92